ID: hyp-SDA-2026-04-04-frontier-proteomics-1
Hypothesis
Synaptic Vesicle Protein Phosphorylation Reprograms Release Probability and Interacts with APP Processing
Synaptic activity-dependent phosphorylation of synapsin-1 by CamKII and calcineurin dynamically regulates vesicle mobilization, while Cdk5-mediated phosphorylation of synaptophysin and SV2A facilitates interaction with APP in presynaptic.
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Synaptic activity-dependent phosphorylation of synapsin-1 by CamKII and calcineurin dynamically regulates vesicle mobilization, while Cdk5-mediated phosphorylation of synaptophysin and SV2A facilitates interaction with APP in presynaptic terminals, creating a hub where impaired neurotransmitter release converges with local Aβ secretion.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Synaptic Activity<br/>Calcium Influx at Active Zone"]
B["CamKII Activation<br/>Synapsin-1 SYN1 Phosphorylation"]
C["SYN1 Dissociates from Reserve Pool<br/>Vesicle Mobilization"]
D["Calcineurin Dephosphorylation<br/>Feedback Vesicle Reclustering"]
E["Cdk5 Aberrant Activation<br/>SYN1 SV2A Synaptophysin Phosphorylation"]
F["Release Probability Reprogrammed<br/>Short-Term Plasticity Disrupted"]
G["APP Processing Modulated<br/>Secretase Access Altered by Vesicle State"]
H["Synaptic Dysfunction<br/>AD ALS Co-pathology"]
A --> B
B --> C
C --> D
D --> B
E --> F
F --> G
E --> H
G --> H
style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports1 contradicts
Supports
Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Supports
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Supports
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Supports
TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation.
Supports
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SYN1
No curated PDB or AlphaFold mapping for SYN1 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SYN1 (Synapsin-1).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0512
Events (7d)
0
Price History
▲5.3%💾 Resource Usage
LLM Tokens
7,768
$0.0265
Total Cost
$0.0265
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we pharmacologically inhibit Cdk5 activity (using roscovitine) in primary hippocampal neurons AND simultaneously measure synaptic vesicle release probability (via FM4-64 destaining assays) and extr | Cdk5 inhibition will reduce extracellular Aβ42 concentration by ≥40% while release probability remains within ±15% of baseline, demonstrating dissociable effect | — no observation — | pending | 0.75 |
| IF we express synapsin-1 S9A phospho-mutant (non-phosphorylatable) in synapsin-1/2 double knockout neurons via viral transduction AND compare to wild-type synapsin-1 rescue, THEN the phospho-mutant wi | S9A-expressing neurons will show ≥50% reduction in synaptic vesicle mobilization (measured as refractory pool replenishment rate) and ≥40% reduction in synaptop | — no observation — | pending | 0.68 |
🔮 Falsifiable Predictions (2)
pendingconf 75%
IF we pharmacologically inhibit Cdk5 activity (using roscovitine) in primary hippocampal neurons AND simultaneously measure synaptic vesicle release probability (via FM4-64 destaining assays) and extracellular Aβ42 levels (via ELISA), THEN neurons will exhibit significantly reduced Aβ42 secretion (≥
Predicted outcome: Cdk5 inhibition will reduce extracellular Aβ42 concentration by ≥40% while release probability remains within ±15% of baseline, demonstrating dissocia
Falsification: If Cdk5 inhibition produces equivalent changes in both release probability AND Aβ secretion (i.e., both change by >30% in the same direction), this would indicate these processes are not independently
pendingconf 68%
IF we express synapsin-1 S9A phospho-mutant (non-phosphorylatable) in synapsin-1/2 double knockout neurons via viral transduction AND compare to wild-type synapsin-1 rescue, THEN the phospho-mutant will demonstrate both reduced synaptic vesicle mobilization during prolonged stimulation AND decreased
Predicted outcome: S9A-expressing neurons will show ≥50% reduction in synaptic vesicle mobilization (measured as refractory pool replenishment rate) and ≥40% reduction i
Falsification: If the S9A mutant shows normal vesicle mobilization but still demonstrates reduced APP interaction, this would indicate synapsin-1 phosphorylation regulates APP processing independently of vesicle dyn
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.